Table of Contents
Ulcers
Volume 2014 (2014), Article ID 361586, 13 pages
http://dx.doi.org/10.1155/2014/361586
Review Article

Herbal Remedy: An Alternate Therapy of Nonsteroidal Anti-Inflammatory Drug Induced Gastric Ulcer Healing

Department of Biochemistry, KPC Medical College & Hospital, Jadavpur, Kolkata 700032, India

Received 27 October 2013; Revised 1 April 2014; Accepted 15 April 2014; Published 6 May 2014

Academic Editor: Tomasz Brzozowski

Copyright © 2014 Ananya Chatterjee and Sandip K. Bandyopadhyay. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Zaman, “The Southeast Asia region,” in Traditional Medicine, R. H. Bannerman, Ed., pp. 231–239, World Health Organization, Geneva, Switzerland, 1974. View at Google Scholar
  2. N. Nakatani, “Phenolic antioxidants from herbs and spices,” BioFactors, vol. 13, no. 1–4, pp. 141–146, 2000. View at Google Scholar · View at Scopus
  3. J. Kanner and T. Lapidot, “The stomach as a bioreactor: dietary lipid peroxidation in the gastric fluid and the effects of plant-derived antioxidants,” Free Radical Biology and Medicine, vol. 31, no. 11, pp. 1388–1395, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Gurbuz, C. Akyuz, E. Yesilada, and B. Sener, “Anti-ulcerogenic effect of Momordica charantia L. fruits on various ulcer models in rats,” Journal of Ethnopharmacology, vol. 71, no. 1-2, pp. 77–82, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Mahadeva and K.-L. Goh, “Epidemiology of functional dyspepsia: a global perspective,” World Journal of Gastroenterology, vol. 12, no. 17, pp. 2661–2666, 2006. View at Google Scholar · View at Scopus
  6. Z. Ge and D. E. Taylor, “Contributions of genome sequencing to understanding the biology of Helicobacter pylori,” Annual Review of Microbiology, vol. 53, pp. 353–387, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. D. R. Cave, “Transmission and epidemiology of Helicobactor pylori,” The American Journal of Medicine, vol. 100, no. 1, pp. 12–17, 1996. View at Publisher · View at Google Scholar
  8. A. Chatterjee, S. Chatterjee, and S. K. Bandyopadhyay, “H. pylori-induced gastric ulcer: pathophysiology and herbal remedy,” International Journal of Biological & Medical Research, vol. 3, no. 1, pp. 1461–1465, 2012. View at Google Scholar
  9. A. S. Tarnawski and M. K. Jones, “Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications,” Journal of Molecular Medicine, vol. 81, no. 10, pp. 627–636, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Brooks, P. Emery, J. F. Evans et al., “Interpreting the clinical significance of the differential inhibition of COX-1 and COX-2,” Rheumatology, vol. 38, no. 8, pp. 779–788, 1999. View at Google Scholar · View at Scopus
  11. A. Lanas, M. A. Perez-Aisa, F. Feu et al., “A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use,” American Journal of Gastroenterology, vol. 100, no. 8, pp. 1685–1693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. E. Moerman, “An analysis of the food plants and drug plants of native North America,” Journal of Ethnopharmacology, vol. 52, no. 1, pp. 1–22, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Hossenbocus and D. G. Colin-Jones, “Proceedings: the effects of aspirin, carbenoxolone, and gefarnate on the gastric mucosal potential difference in man,” Gut, vol. 15, no. 4, pp. 335–336, 1974. View at Google Scholar · View at Scopus
  14. Y. Katoh, M. Tanaka, and H. Kawashima, “Protective effects of teprenone and gefarnate against taurocholate/hydrochloric acid-induced acute gastric mucosal lesions in rats,” Nippon Yakurigaku Zasshi, vol. 112, no. 5, pp. 323–331, 1998. View at Google Scholar
  15. D. G. Payan and B. G. Katzung, “Non-steroidal anti-inflammatory drugs; nonopoid analgesics; drugs used in gout,” Basic and Clinical Pharmacology, vol. 6, pp. 536–559, 1995. View at Google Scholar
  16. L. Brunton, B. Chabner, and B. Knollman, “Anti-inflammatory, antipyretic, and analgesic agents: pharmacotherapy of gout,” in The Pharmacological Basis of Therapeutics, W. H. Freeman, Ed., Goodman and Gilman’s, pp. 959–1004, Mcgraw-Hill, New York, NY, USA, 12th edition, 2011. View at Google Scholar
  17. T. Yoshikawa, Y. Naito, A. Kishi et al., “Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats,” Gut, vol. 34, no. 6, pp. 732–737, 1993. View at Google Scholar · View at Scopus
  18. C. J. Hawkey and D. S. Rampton, “Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?” Gastroenterology, vol. 89, no. 5, pp. 1162–1188, 1985. View at Google Scholar · View at Scopus
  19. K. Wong and K. Freund, “Inhibition of the n-formylmethionyl-leucyl-phenylalanine induced respiratory burst in human neutrophils by adrenergic agonists and prostaglandins of the E series,” Canadian Journal of Physiology and Pharmacology, vol. 59, no. 9, pp. 915–920, 1981. View at Google Scholar · View at Scopus
  20. M. K. Jones, H. Wang, B. M. Peskar et al., “Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing,” Nature Medicine, vol. 5, no. 12, pp. 1418–1423, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Wallace, “Recent advances in gastric ulcer therapeutics,” Current Opinion in Pharmacology, vol. 5, no. 6, pp. 573–577, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. N. Muscara and J. L. Wallace, “Nitric oxide. V. therapeutic potential of nitric oxide donors and inhibitors,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 276, no. 6, part 1, pp. G1313–G1316, 1999. View at Google Scholar · View at Scopus
  23. J. L. Wallace, C. M. Keenan, and D. N. Granger, “Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 259, no. 3, part 1, pp. G462–G467, 1990. View at Google Scholar · View at Scopus
  24. J. Piotrowski, A. Slomiany, and B. L. Slomiany, “Activation of apoptotic caspase-3 and nitric oxide synthase-2 in gastric mucosal injury induced by indomethacin,” Scandinavian Journal of Gastroenterology, vol. 34, no. 2, pp. 129–134, 1999. View at Google Scholar · View at Scopus
  25. J. L. Wallace and M. J. Miller, “Nitric oxide in mucosal defense: a little goes a long way,” Gastroenterology, vol. 119, no. 2, pp. 512–520, 2000. View at Google Scholar · View at Scopus
  26. C. J. Hawkey, “Non-steroidal anti-inflammatory drugs and peptic ulcers. Facts and figures multiply, but do they add up?” British Medical Journal, vol. 300, no. 6720, pp. 278–284, 1990. View at Google Scholar · View at Scopus
  27. M. J. Lancaster-Smith, M. R. Jaderberg, and D. A. Jackson, “Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers,” Gut, vol. 32, no. 3, pp. 252–256, 1991. View at Google Scholar
  28. F. Halter, A. S. Tarnawski, A. Schmassmann, and B. M. Peskar, “Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives,” Gut, vol. 49, no. 3, pp. 443–453, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Baatar, M. K. Jones, R. Pai et al., “Selective COX-2 blocker delays healing of experimental esophageal ulcers and inhibits ulceration-triggered c-Met/HGF receptor induction and ERK2 activation,” The American Journal of Gastroenterology, vol. 97, pp. 542–553, 2002. View at Publisher · View at Google Scholar
  30. L. Ma, P. D. Soldato, and J. L. Wallace, “Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: shifting the angiogenic balance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 20, pp. 13243–13247, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. K. Jones, H. Wang, B. M. Peskar et al., “Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing,” Nature Medicine, vol. 5, no. 12, pp. 1418–1423, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Pawlik, P. C. Konturek, J. W. Konturek et al., “Impact of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on gastric ulcerogenesis in experimental animals and in humans,” European Journal of Pharmacology, vol. 449, no. 1-2, pp. 1–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Brzozowski, P. C. Konturek, Z. Liwowski et al., “Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals,” Journal of Physiology and Pharmacology, vol. 57, no. 3, pp. 67–79, 2006. View at Google Scholar · View at Scopus
  34. M. Karthikeyan and K. Deepa, “Therapeutic applications of nitric oxide releasing non steroidal anti-inflammatory drugs,” Journal of Chemical and Pharmaceutical Research, vol. 1, no. 1, pp. 134–147, 2009. View at Google Scholar
  35. K. Takeuchi, H. Ukawa, A. Konaka, M. Kitamura, and Y. Sugawa, “Effect of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: comparison with plain aspirin,” Journal of Pharmacology and Experimental Therapeutics, vol. 286, no. 1, pp. 115–121, 1998. View at Google Scholar · View at Scopus
  36. S. Fiorucci and L. Santucci, “Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDs,” Inflammation & Allergy Drug Targets, vol. 10, no. 2, pp. 133–140, 2011. View at Google Scholar · View at Scopus
  37. L. Zhi, A. D. Ang, H. Zhang, P. K. Moore, and M. Bhatia, “Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-κB pathway,” Journal of Leukocyte Biology, vol. 81, no. 5, pp. 1322–1332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Caliendo, G. Cirino, V. Santagada, and J. L. Wallace, “Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals,” Journal of Medicinal Chemistry, vol. 53, no. 17, pp. 6275–6286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Cristoni and M. J. Magistretti, “Antiulcer and healing activity of Vaccinium myrtillus anthocyandosides,” Il Farmaco, vol. 42, no. 2, pp. 29–43, 1987. View at Google Scholar · View at Scopus
  40. M. J. Magistretti, M. Conti, and A. Cristoni, “Antiulcer activity of an anthocyanidin from Vaccinium myrtillus,” Arzneimittel Forschung, vol. 38, no. 5, pp. 686–690, 1988. View at Google Scholar · View at Scopus
  41. T. Al-Howiriny, A. Alsheikh, S. Alqasoumi, M. Al-Yahya, K. Eltahir, and S. Rafatullah, “Gastric antiulcer, antisecretory and cytoprotective properties of celery (Apium graveolens) in rats,” Pharmaceutical Biology, vol. 48, no. 7, pp. 786–793, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Shibata, R. Yoshida, S. Motohashi, and M. Fukushima, “Pharmacologic studies on Bupleurum falcatum L. IV. Some pharmacologic effects of crude saikosides, saikogenin A and syrupy residue,” Yakugaku Zasshi, vol. 93, no. 12, pp. 1660–1667, 1973. View at Google Scholar · View at Scopus
  43. H. Yamada, K.-S. Ra, H. Kiyohara, J.-C. Cyong, and Y. Otsuka, “Structural characterisation of an anti-complementary pectic polysaccharide from the roots of Bupleurum falcatum L,” Carbohydrate Research, vol. 189, pp. 209–226, 1989. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Swarnakar, K. Ganguly, P. Kundu, A. Banerjee, P. Maity, and A. V. Sharma, “Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer,” The Journal of Biological Chemistry, vol. 280, no. 10, pp. 9409–9415, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. M.-T. Huang, T. Lysz, T. Ferraro, T. F. Abidi, J. D. Laskin, and A. H. Conney, “Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis,” Cancer Research, vol. 51, no. 3, pp. 813–819, 1991. View at Google Scholar · View at Scopus
  46. C. Niederau and E. Gopfert, “The effect of chelidonium- and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study,” Medizinische Klinik, vol. 94, no. 8, pp. 425–430, 1999. View at Google Scholar · View at Scopus
  47. C. Prucksunand, B. Indrasukhsri, M. Leethochawalit, and K. Hungspreugs, “Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 32, no. 1, pp. 208–215, 2001. View at Google Scholar · View at Scopus
  48. F. Zhang, N. K. Altorki, J. R. Mestre, K. Subbaramaiah, and A. J. Dannenberg, “Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells,” Carcinogenesis, vol. 20, no. 3, pp. 445–451, 1999. View at Google Scholar · View at Scopus
  49. M. Yoshikawa, T. Morikawa, N. Li, A. Nagatomo, X. Li, and H. Matsuda, “Bioactive saponins and glycosides. XXIII. Triterpene saponins with gastroprotective effect from the seeds of Camellia sinensis—theasaponins E3, E4, E5, E6, and E7,” Chemical & Pharmaceutical Bulletin, vol. 53, no. 12, pp. 1559–1564, 2005. View at Google Scholar · View at Scopus
  50. T. Morikawa, N. Li, A. Nagatomo, H. Matsuda, X. Li, and M. Yoshikawa, “Triterpene saponins with gastroprotective effects from tea seed (the seeds of Camellia sinensis),” Journal of Natural Products, vol. 69, no. 2, pp. 185–190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Maity, J. R. Vedasiromoni, L. Chaudhuri, and D. K. Ganguly, “Role of reduced glutathione and nitric oxide in the black tea extract-mediated protection against ulcerogen-induced changes in motility and gastric emptying in rats,” Japanese Journal of Pharmacology, vol. 85, no. 4, pp. 358–364, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Maity, J. R. Vedasiromoni, and D. K. Ganguly, “Anti-ulcer effect of the hot water extract of black tea (Camellia sinensis),” Journal of Ethnopharmacology, vol. 46, no. 3, pp. 167–174, 1995. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Adhikary, S. K. Yadav, K. Roy, S. K. Bandyopadhyay, and S. Chattopadhyay, “Black tea and theaflavins assist healing of indomethacin-induced gastric ulceration in mice by antioxidative action,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 546560, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. J. A. Duke, Handbook of Medicinal Herbs, CRC Press, Boca Raton, Fla, USA, 1985.
  55. A. G. Turpie, J. Runcie, and T. J. Thomson, “Clinical trial of deglydyrrhizinized liquorice in gastric ulcer,” Gut, vol. 10, no. 4, pp. 299–302, 1969. View at Google Scholar · View at Scopus
  56. P. A. Bafna and R. Balaraman, “Anti-ulcer and anti-oxidant activity of Pepticare, a herbomineral formulation,” Phytomedicine, vol. 12, no. 4, pp. 264–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. A. R. Dehpour, M. E. Zolfaghari, T. Samadian, and Y. Vahedi, “The protective effect of liquorice components and their derivatives against gastric ulcer induced by aspirin in rats,” Journal of Pharmacy and Pharmacology, vol. 46, no. 2, pp. 148–149, 1994. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Matsuda, Y. Li, T. Murakami, J. Yamahara, and M. Yoshikawa, “Protective effects of oleanolic acid oligoglycosides on ethanol- or indomethacin-induced gastric mucosal lesions in rats,” Life Sciences, vol. 63, no. 17, pp. PL245–PL250, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Saito, Y. M. Lee, K. Takagi, S. Shoji, and N. Kondo, “Pharmacological studies of Panacis japonici rhizoma,” Chemical and Pharmaceutical Bulletin, vol. 25, no. 5, pp. 1017–1025, 1977. View at Google Scholar
  60. V. B. Mehta, V. J. Sharma, M. F. Shaikh, P. D. Amin, and S. Sathaye, “Evaluation of antioxidant and immunomodulatory activity of Lagenaria vulgaris,” International Journal of Research in Pharmaceutical Sciences, vol. 2, no. 3, pp. 393–398, 2011. View at Google Scholar · View at Scopus
  61. F. Khanom, H. Kayahara, and K. Tadasa, “Superoxide-scavenging and prolyl endopeptidase inhibitory activities of Bangladeshi indigenous medicinal plants,” Bioscience, Biotechnology and Biochemistry, vol. 64, no. 4, pp. 837–840, 2000. View at Google Scholar · View at Scopus
  62. D. Banerjee, A. K. Bauri, R. K. Guha, S. K. Bandyopadhyay, and S. Chattopadhyay, “Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action,” European Journal of Pharmacology, vol. 578, no. 2-3, pp. 300–312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Banerjee, B. Maity, A. K. Bauri, S. K. Bandyopadhyay, and S. Chattopadhyay, “Gastroprotective properties of Myristica malabarica against indometacin-induced stomach ulceration: a mechanistic exploration,” Journal of Pharmacy and Pharmacology, vol. 59, no. 11, pp. 1555–1565, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Maity and S. Chattopadhyay, “Natural antiulcerogenic agents: an overview,” Current Bioactive Compounds, vol. 4, no. 4, pp. 225–244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. X.-B. Sun, T. Matsumoto, and H. Yamada, “Purification of an anti-ulcer polysaccharide from the leaves of Panax ginseng,” Planta Medica, vol. 58, no. 5, pp. 445–448, 1992. View at Publisher · View at Google Scholar · View at Scopus
  66. M. T. Khan, I. Lampronti, D. Martello et al., “Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines,” International journal of oncology, vol. 21, no. 1, pp. 187–192, 2002. View at Google Scholar · View at Scopus
  67. E. Lambertini, R. Piva, M. T. Khan et al., “Effects of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines and expression of estrogen receptor alpha gene,” International Journal of Oncology, vol. 24, no. 2, pp. 419–423, 2004. View at Google Scholar · View at Scopus
  68. A. Ihantola-Vormisto, J. Summanen, H. Kankaanranta, H. Vuorela, Z. M. Asmawi, and E. Moilanen, “Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica,” Planta Medica, vol. 63, no. 6, pp. 518–524, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. S. K. Bandyopadhyay, S. C. Pakrashi, and A. Pakrashi, “The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer,” Journal of Ethnopharmacology, vol. 70, no. 2, pp. 171–176, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. Singh and Sharma, “Acid balancing effect on digestive system: clinical studies were conducted to investigate the effect of amalaki in amlapitta (Gastritis syndrome),” Indian Journal of Medical Research, vol. 34, pp. 98–99, 1971. View at Google Scholar
  71. A. Chatterjee, S. Chattopadhyay, and S. K. Bandyopadhyay, “Biphasic effect of Phyllanthus emblica L. extract on NSAID-induced ulcer: an antioxidative trail weaved with immunomodulatory effect,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 146808, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Chatterjee, S. Chatterjee, S. Das, A. Saha, S. Chattopadhyay, and S. K. Bandyopadhyay, “Ellagic acid facilitates indomethacin-induced gastric ulcer healing via COX-2 up-regulation,” Acta Biochimica et Biophysica Sinica, vol. 44, no. 7, pp. 565–576, 2012. View at Publisher · View at Google Scholar
  73. A. Chatterjee, S. Chatterjee, A. Biswas, S. Bhattecharya, S. Chattopadhyay, and S. K. Bandyopadhyay, “Gallic acid enriched fraction of Phyllanthus emblica potentiates indomethacin-induced gastric ulcer healing via e-NOS-dependent pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 487380, 13 pages, 2012. View at Publisher · View at Google Scholar
  74. Y. Dwivedi, R. Rastogi, N. K. Garg, and B. N. Dhawan, “Picroliv and its components kutkoside and picroside I protect liver against galactosamine-induced damage in rats,” Pharmacology & Toxicology, vol. 71, no. 5, pp. 383–387, 1992. View at Google Scholar · View at Scopus
  75. D. Banerjee, S. Bhattacharya, S. K. Bandyopadhyay, and S. Chattopadhyay, “Picrorhiza kurroa—phytochemical and pharmacological evaluation,” in Recent Progress in Medicinal Plants, J. N. Govil, Ed., vol. 24, pp. 69–89, Stadium Press, Houston, Tex, USA, 2009. View at Google Scholar
  76. H. Panda, Herbs Cultivation and Medicinal Uses, National Institute of Industrial Re, Delhi, India, 2004.
  77. S. Bhattacharya, D. Banerjee, A. K. Bauri, S. Chattopadhyay, and S. K. Bandyopadhyay, “Healing property of the Piper betel phenol, allylpyrocatechol against indomethacin-induced stomach ulceration and mechanism of action,” World Journal of Gastroenterology, vol. 13, no. 27, pp. 3705–3713, 2007. View at Google Scholar · View at Scopus
  78. B. Majumdar, S. R. Chaudhuri, A. Ray, and S. K. Bandyopadhyay, “Potent antiulcerogenic activity of ethanol extract of leaf of Piper betle linn by antioxidative mechanism,” Indian Journal of Clinical Biochemistry, vol. 17, no. 1, pp. 49–57, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. S. K. Yadav, B. Adhikary, B. Maity, S. K. Bandyopadhyay, and S. Chattopadhyay, “The gastric ulcer-healing action of allylpyrocatechol is mediated by modulation of arginase metabolism and shift of cytokine balance,” European Journal of Pharmacology, vol. 614, no. 1–3, pp. 106–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Al-Said, A. Ageel, N. S. Parmar, and M. Tariq, “Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity,” Journal of Ethnopharmacology, vol. 15, no. 3, pp. 271–278, 1986. View at Publisher · View at Google Scholar · View at Scopus
  81. R. de Pasquale, M. P. Germano, A. Keita, R. Sanogo, and L. Iauk, “Antiulcer activity of Pteleopsis suberosa,” Journal of Ethnopharmacology, vol. 47, no. 1, pp. 55–58, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. M. P. Germanò, R. Sanogo, M. Guglielmo, R. de Pasquale, G. Crisafi, and G. Bisignano, “Effects of Pteleopsis suberosa extracts on experimental gastric ulcers and Helicobacter pylori growth,” Journal of Ethnopharmacology, vol. 59, no. 3, pp. 167–172, 1998. View at Publisher · View at Google Scholar · View at Scopus
  83. R. K. Goel, R. S. Banerjee, and S. B. Acharya, “Antiulcerogenic and antiinflammatory studies with shilajit,” Journal of Ethnopharmacology, vol. 29, no. 1, pp. 95–103, 1990. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Bindoli, S. Cavallini, and N. Siliprandi, “Accion inhibidora de la silimarina sobre la peroxidacion lipidica en los microsomas y mitocondrias hepaticos de la rata,” Biochemical Pharmacology, vol. 26, pp. 2405–2409, 1977. View at Google Scholar
  85. C. Alarcon de la Lastra, M. J. Martin, and E. Marhuenda, “Gastric anti-ulcer activity of silymarin, a lipoxygenase inhibitor, in rats,” Journal of Pharmacy and Pharmacology, vol. 44, no. 11, pp. 929–931, 1992. View at Google Scholar · View at Scopus
  86. K. Kyogoku, K. Hatayama, S. Yokomori et al., “Anti-ulcer effect of isoprenyl flavonoids. Synthesis and anti-ulcer activity of new chalone related to sophoradain,” Chemical & Pharmaceutical Bulletin, vol. 27, no. 12, pp. 2943–2948, 1979. View at Google Scholar
  87. J. Petersson, M. Phillipson, E. A. Jansson, A. Patzak, J. O. Lundberg, and L. Holm, “Dietary nitrate increases gastric mucosal blood flow and mucosal defense,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 292, no. 3, pp. G718–G724, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. H. Bjorne, J. Petersson, M. Phillipson, E. Weitzberg, L. Holm, and J. O. Lundberg, “Nitrite in saliva increases gastric mucosal blood flow and mucus thickness,” The Journal of Clinical Investigation, vol. 113, no. 1, pp. 106–114, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. R. K. Goel, N. K. R. Pathak, and M. Biswas, “Effect of lapachol, a naphthaquinone isolated from Tectona grandis, on experimental peptic ulcer and gastric secretion,” Journal of Pharmacy and Pharmacology, vol. 39, no. 2, pp. 138–140, 1987. View at Google Scholar · View at Scopus
  90. R. K. Sanyal, P. K. Das, S. Sinha, and Y. K. Sinha, “Banana and gastric secretion,” Journal of Pharmacy and Pharmacology, vol. 13, no. 1, pp. 318–319, 1961. View at Publisher · View at Google Scholar · View at Scopus
  91. A. K. Sanyal, K. K. Gupta, and N. K. Chowdhury, “Banana and experimental peptic ulcer,” Journal of Pharmacy and Pharmacology, vol. 15, no. 1, pp. 283–284, 1963. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Best, D. A. Lewis, and N. Nasser, “The anti-ulcerogenic activity of the unripe plantain banana (Musa species),” British Journal of Pharmacology, vol. 82, no. 1, pp. 107–116, 1984. View at Google Scholar · View at Scopus
  93. R. C. Elliott and G. J. F. Heward, “The influence of a banana supplemented diet on gastric ulcers in mice,” Pharmacological Research Communications, vol. 8, no. 2, pp. 167–171, 1976. View at Google Scholar · View at Scopus
  94. R. K. Goel, S. Gupta, R. K. Shankar, and A. K. Sanyal, “Anti-ulcerogenic effect of banana powder (Musa sapientum varpara paradisiaca) and its effect on mucosal resistance,” Journal of Ethnopharmacology, vol. 18, no. 1, pp. 33–44, 1986. View at Google Scholar
  95. R. K. Goel, I. A. Tavares, and A. Bennett, “Stimulation of gastric and colonic mucosal eicosanoid synthesis by plantain banana,” Journal of Pharmacy and Pharmacology, vol. 41, no. 11, pp. 747–750, 1989. View at Publisher · View at Google Scholar
  96. M. Stuart, The Encyclopedia of Herbs and Herbalism, Orbis, London, UK, 1979.
  97. A. M. Ageel, J. S. Mossa, M. Tariq, M. A. Al-Yahya, and M. S. Al-Said, Plants Used in Saudi Folk Medicine, King Saud University Press, Riyadh, Saudi Arabia, 1987.
  98. J. D. Keys, Chinese Herbs, Tuttle Company, Tokyo, Japan, 3rd edition, 1985.
  99. D. B. Mowrey and D. E. Clayson, “Motion sickness, ginger, and psychophysics,” The Lancet, vol. 1, no. 8273, pp. 655–657, 1982. View at Google Scholar · View at Scopus
  100. M. A. Al-Yahya, S. Rafatullah, J. S. Mossa, A. M. Ageel, N. S. Parmar, and M. Tariq, “Gastroprotective activity of ginger Zingiber officinale rose, in albino rats,” American Journal of Chinese Medicine, vol. 17, no. 1-2, pp. 51–56, 1989. View at Google Scholar · View at Scopus
  101. W. Toma, J. R. Trigo, A. C. B. Paula, and A. R. M. S. Brito, “Preventive activity of pyrrolizidine alkaloids from Senecio brasiliensis (Asteraceae) on gastric and duodenal induced ulcer on mice and rats,” Journal of Ethnopharmacology, vol. 95, no. 2-3, pp. 345–351, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. F. Borrelli and A. A. Izzo, “The plant kingdom as a source of anti-ulcer remedies,” Phytotherapy Ressearch, vol. 14, no. 8, pp. 581–591, 2000. View at Google Scholar
  103. P. Toniolo, A. L. van Kappel, A. Akhmedkhanov et al., “Serum carotenoids and breast cancer,” American Journal of Epidemiology, vol. 153, no. 12, pp. 1142–1147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. C. A. Swanson, “Vegetables, fruits, and cander risk: the role of phytochemicals,” in Phytochemicals: A New Paradigm, W. R. Bidlack, S. T. Omaye, M. S. Meskin, and D. Johner, Eds., pp. 1–12, Technomic, Lancaster, Pa, USA, 1998. View at Google Scholar
  105. V. Brower, “Nutraceuticals: poised for a healthy slice of the healthcare market?” Nature Biotechnology, vol. 16, no. 8, pp. 728–731, 1998. View at Publisher · View at Google Scholar · View at Scopus
  106. G. Block, B. Patterson, and A. Subar, “Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence,” Nutrition and Cancer, vol. 18, no. 1, pp. 1–29, 1992. View at Google Scholar · View at Scopus
  107. D. Trichopoulos and W. C. Willett, “Introduction: nutrition and cancer,” Cancer Causes & Control, vol. 7, no. 1, pp. 3–4, 1996. View at Publisher · View at Google Scholar · View at Scopus
  108. K. A. Steinmetz and J. D. Potter, “Vegetables, fruit, and cancer. II. Mechanisms,” Cancer Causes & Control, vol. 2, no. 6, pp. 427–442, 1991. View at Publisher · View at Google Scholar · View at Scopus
  109. G. di Carlo, N. Mascolo, A. A. Izzo, and F. Capasso, “Flavonoids: old and new aspects of a class of natural therapeutic drugs,” Life Sciences, vol. 65, no. 4, pp. 337–353, 1999. View at Publisher · View at Google Scholar · View at Scopus
  110. M. J. Alcaraz and J. R. Hoult, “Actions of flavonoids and the novel anti-inflammatory flavone, hypolaetin-8-glucoside, on prostaglandin biosynthesis and inactivation,” Biochemical Pharmacology, vol. 34, no. 14, pp. 2477–2482, 1985. View at Publisher · View at Google Scholar · View at Scopus
  111. C. Bronner and Y. Landry, “Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells,” Agents and Actions, vol. 16, no. 3-4, pp. 147–151, 1985. View at Google Scholar · View at Scopus
  112. W. Beil, C. Birkholz, and K.-F. Sewing, “Effects of flavonoids on parietal cell acid secretion, gastric mucosal prostaglandin production and Helicobacter pylori growth,” Arzneimittel Forschung, vol. 45, no. 6, pp. 697–700, 1995. View at Google Scholar · View at Scopus
  113. J. Baumann, G. Wurm, and F. Bruchhausen, “Prostaglandin synthetase inhibition by flavonoids and phenolic compounds in relation to their oxygen-scavenging properties,” Archiv der Pharmazie, vol. 313, no. 4, pp. 330–337, 1980. View at Google Scholar
  114. L. Cavallini, A. Bindoli, and N. Siliprandi, “Comparative evaluation of antiperoxidative action of silymarin and other flavonoids,” Pharmacological Research Communications, vol. 10, no. 2, pp. 133–136, 1978. View at Google Scholar · View at Scopus
  115. R. Salvayre, P. Braquet, L. Perruchot, and L. Douste-Blazy, “Comparison of the scavenger effect of bilberry anthocyanosides with various favonoids,” Flavonoids Bioflavonoids, vol. 11, pp. 437–442, 1982. View at Google Scholar
  116. M.-A. Moroney, M. J. Alcaraz, R. A. Forder, F. Carey, and S. R. S. Hoult, “Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids,” Journal of Pharmacy and Pharmacology, vol. 40, no. 11, pp. 787–792, 1988. View at Google Scholar
  117. A. A. Izzo, G. di Carlo, N. Mascolo, G. Autore, and F. Capasso, “Antiulcer effect of flavonoids. Role of endogenous PAF,” Phytotherapy Research, vol. 8, no. 3, pp. 179–181, 1994. View at Publisher · View at Google Scholar · View at Scopus
  118. C. Alarcon de la Lastra, M. J. Martin, and V. Motilva, “Antiulcer and gastroprotective effects of quercetin: a gross and histologic study,” Pharmacology, vol. 48, no. 1, pp. 56–62, 1994. View at Google Scholar · View at Scopus
  119. M. J. Martin, C. la Casa, C. Alarcon de la Lastra, J. Cabeza, I. Villegas, and V. Motilva, “Anti-oxidant mechanisms involved in gastroprotective effects of quercetin,” Zeitschrift für Naturforschung, vol. 53, no. 1-2, pp. 82–88, 1998. View at Google Scholar · View at Scopus
  120. N. S. Parmar, “The gastric anti-ulcer activity of naringenin, a specific histidine decarboxylase inhibitor,” International Journal of Tissue Reactions, vol. 5, no. 4, pp. 415–420, 1983. View at Google Scholar · View at Scopus
  121. M. J. Martin, V. Motilva, and C. Alarcon de la Lastra, “Quercetin and naringenin: effects on ulcer formation and gastric secretion in rats,” Phytotherapy Research, vol. 7, no. 2, pp. 150–153, 1993. View at Google Scholar · View at Scopus
  122. V. Motilva, C. Alarcon de la Lastra, M. J. Martin, and J. Torreblanca, “Effects of naringenin and quercetin on experimental chronic gastric ulcer in rat. Studies on the histological findings,” Phytotherapy Research, vol. 6, no. 3, pp. 168–170, 1992. View at Publisher · View at Google Scholar · View at Scopus
  123. V. Motilva, C. Alarcon de la Lastra, and M. J. Martin, “Ulcer-protecting effects of naringenin on gastric lesions induced by ethanol in rat: role of endogenous prostaglandins,” Journal of Pharmacy and Pharmacology, vol. 46, no. 2, pp. 91–94, 1994. View at Publisher · View at Google Scholar · View at Scopus
  124. J. Robak and R. Gryglewski, “Flavonoids are scavengers of superoxide anions,” Biochemical Pharmacology, vol. 37, no. 5, pp. 837–841, 1988. View at Google Scholar · View at Scopus
  125. J. Robak, F. Shridi, M. Wolbis, and M. Kerolikowska, “Screening of the influence of flavonoids on lipoxygenase and cyclooxygenase activity, as well as on nonenzymic lipid oxidation,” Polish Journal of Pharmacology and Pharmacy, vol. 40, no. 5, pp. 451–458, 1988. View at Google Scholar · View at Scopus
  126. M. J. Martin, E. Marhuenda, C. Perez-Guerrero, and J. M. Franco, “Antiulcer effect of naringin on gastric lesions induced by ethanol in rats,” Pharmacology, vol. 49, no. 3, pp. 144–150, 1994. View at Google Scholar · View at Scopus
  127. J. L. Wallace, “Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years,” Gastroenterology, vol. 112, no. 3, pp. 1000–1016, 1997. View at Publisher · View at Google Scholar · View at Scopus